Grantham, Mayo, Van Otterloo & Co (GMO)’s Thomson Reuters TRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
– Sell
-3,891
Closed -$408K – 766
2021
Q2
$408K Hold
3,891
– – ﹤0.01% 641
2021
Q1
$359K Buy
+3,891
New +$346K ﹤0.01% 757

Other funds holding TRI

Grantham, Mayo, Van Otterloo & Co (GMO)'s TRI Position: Q3 2021 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Thomson Reuters (TRI) in Q3 2021, closing a stake of 3,891 shares — an estimated $408K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in TRI in Q1 2021 and held it in 2 quarters. The position peaked at $408K in Q2 2021. 387 funds tracked by Wall St. Rank hold TRI as of Q3 2021.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Thomson Reuters position as of Q3 2021 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 3,891 Thomson Reuters shares in Q3 2021, an estimated $408K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Thomson Reuters in Q1 2021 and held it in 2 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Thomson Reuters position peaked at $408K in Q2 2021.
  • 387 funds tracked by Wall St. Rank held Thomson Reuters as of Q3 2021.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2021, filed 12 Nov 2021.